dc.creatorThielemann, A. M.
dc.creatorManquez, N.
dc.creatorPinilla, E.
dc.creatorGai, M. N.
dc.creatorRomero, P.
dc.creatorArancibia, A.
dc.creatorChavez, H.
dc.date.accessioned2018-12-20T15:09:16Z
dc.date.available2018-12-20T15:09:16Z
dc.date.created2018-12-20T15:09:16Z
dc.date.issued1996
dc.identifierInternational Journal of Clinical Pharmacology and Therapeutics, Volumen 34, Issue 3, 2018, Pages 130-133
dc.identifier09461965
dc.identifierhttps://repositorio.uchile.cl/handle/2250/157998
dc.description.abstractThe result obtained from different studies of the chronopharmacokinetics of some controlled-release tablets of theophylline are variable, since some authors report differences while others do not. At our laboratory we have developed a formulation of a control-led-release theophylline tablet using acrylic resins and we studied the chronopharmacokinetics of theophylline from this dosage form. Seven Caucasian healthy male volunteers participated in the study approved by the Institutional Review Board (IRB). Each volunteer received a controlled release tablet of 300 mg theophylline and an i.v. dose equivalent to 131.46 mg theophylline once at 8.00 a.m. and once at 8.00 p.m. Theophylline plasma concentrations were determined by HPLC. The following pharmacokinetic parameters were calculated: maximum concentration, time to reach maximum concentration, mean residence time, absorption constant, area under the curve of plasma concentration versus time, distribution volume (Vdβ), and total cleara
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceInternational Journal of Clinical Pharmacology and Therapeutics
dc.subjectChronopharmacokinetics
dc.subjectControlled-release tablets
dc.subjectTheophylline
dc.titleChronopharmacokinetics of theophylline administered as a controlled-release tablet
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución